GC
KLRS

GMT Capital’s Kalaris Therapeutics KLRS Stock Holding History

GMT Capital’s Portfolio KLRS Stock Details KLRS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
2023
Q3 		$9.05M Buy
2023
Q2 		$14M Buy
2023
Q1 		$13.1M Buy
2022
Q4 		$14.2M Hold
2022
Q3 		$21.8M Buy
2022
Q2 		$7.38M Buy
2022
Q1 		$7.68M Buy
2021
Q4 		$8.69M Buy
2021
Q3 		$11.9M Buy